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formula in which a is the ﬁ  rst order 
error (5%):
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Because of the change in sample size, 
the limit prevalence was redetermined 
by using the inverse of the formula 
above:
n a p − =1  
If at least 1 sample was positive for 
M. bovis, the prevalence of bovine 
TB among patients would be >4.2%. 
However, the prevalence of M. bovis 
was <4.2% and conﬁ  rmed the low-
level involvement of M. bovis in hu-
man TB in Mbarara district. These 
ﬁ  ndings are consistent with previous 
work in Uganda’s capital, Kampala, 
and in other African or Asian coun-
tries (2,8,9). The estimation of extra-
pulmonary cases among all TB cases 
(95% conﬁ  dence interval 2%–15.2%) 
did not differ from the ofﬁ  cial esti-
mate. We can add, using the second 
formula shown above, that among 
the 6 extrapulmonary TB cases, the 
prevalence of M. bovis is <39.3%. 
Our results come from a population 
in a highly rural area (91.5% of the 
population in Mbarara district) (7), 
where the high prevalence of animal 
TB has been reported.
These results could be explained 
by the patients’ consumption habits, 
which reduce the risk for contamina-
tion. Even if bovine TB could also be 
found in other farm or wild animals, 
it seems to have a minor effect on 
public health. Zoonotic TB appeared 
to not be a major public health prob-
lem in Mbarara district. However, 
this ﬁ  nding could also result from un-
derdiagnosis of extrapulmonary TB, 
from prevalence of M. tuberculosis 
being so high that in proportion M. 
bovis is a minor problem, or from ru-
ral populations’ difﬁ  cult access to TB 
diagnosis (directly observed therapy 
case detection rate in Uganda in 2005 
was 37%) (1).
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Vertical 
Transmission of 
Pneumocystis 
jirovecii in Humans 
To the Editor: Currently, animal 
and human studies favor an airborne 
transmission pattern for Pneumocystis 
pneumonia (1). However, the early 
age of acquisition of Pneumocystis 
spp. in different mammals, including 
humans, warrants study of vertical/
transplacental transmission as an ad-
ditional route of transmission of this 
stenoxenic microorganism.
Available studies on transplacen-
tal transmission of Pneumocystis spp. 
suggest that it varies among mammal 
species on the basis of the type of 
placenta (2). Transplacental transmis-
sion of Pneumocystis spp. has been 
demonstrated in rabbits (2,3), but it 
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seems not to occur in rats and mice 
that have severe combined immuno-
deﬁ  ciency (1). In humans, transpla-
cental transmission was ﬁ  rst suggest-
ed by a few reports of Pneumocystis 
spp. pneumonia in neonates published 
before the AIDS epidemic (4). Re-
cently, a controversial case of verti-
cal transmission of P. jirovecii was 
reported: an infection  in the lungs 
of a fetus of an HIV-positive mother 
with  Pneumocystis spp. pneumonia 
(5). However, the study did not iden-
tify the organisms as Pneumocystis, 
and a subsequent ﬂ  uorescein-labeled 
monoclonal antibody test yielded 
negative results (6).
The present study was conducted 
to evaluate transplacental transmis-
sion of P. jirovecii by molecular tech-
niques. Placentas and lung tissues of 
aborted fetuses from immunocom-
petent women who had miscarriages 
were studied. To enhance speciﬁ  c-
ity of the study, we used 2 genetic 
loci in Pneumocystis spp. DNA: the 
mitochondrial large subunit rRNA 
(mtLSU-rRNA) gene and the gene 
encoding for dihydropteroate syn-
thase (DHPS). We analyzed 40 paraf-
ﬁ  n-embedded tissue blocks from the 
placentas and lungs of 20 fetuses at 
28 ± 8 weeks of gestation. The study 
was reviewed and approved by the 
ethical committee of University Hos-
pital, Seville, Spain.
DNA was extracted from a mix-
ture of ﬁ  ve 10-μm sections of each 
tissue block. Histologic sections were 
processed by using xylene and ethanol 
for parafﬁ  n removal and were then re-
hydrated. DNA was extracted by us-
ing the QIAamp DNA Mini Kit (QIA-
GEN, Hilden, Germany) following the 
manufacturer’s instructions.
DNA ampliﬁ  cation at the mtLSU-
rRNA locus was conducted by using 
nested PCR as described (7). Samples 
identiﬁ  ed as positive by this PCR were 
ampliﬁ  ed by using primers DHPS-3 
and DHPS-4 to detect the DHPS gene 
(7). To prevent false-positive results 
caused by contamination, pipettes with 
ﬁ  lters were used at all stages. DNA 
extraction, preparation of the reaction 
mixture, PCR ampliﬁ  cation, and detec-
tion were conducted in different areas 
under a laminar ﬂ  ow hood. Positive 
and negative controls were included 
in each reaction. All experiments were 
repeated at least twice.
P. jirovecii genotypes can be 
characterized by identifying polymor-
phisms at the mtLSU-rRNA locus (po-
sitions 85 and 248) and at the DHPS 
locus (positions 55 and 57). Amplicons 
from all samples that yielded positive 
PCR results for the 2 loci were se-
quenced directly from both ends by 
using a model ABI 377 automated 
sequencer and an ABI prism Dye Ter-
minator cycle sequencing kit (Applied 
Biosystems, Foster City, CA, USA) 
following the manufacturer’s instruc-
tions. The derived mtLSU-rRNA and 
DHPS gene sequences were compared 
with sequences available in databases 
by using the National Center for Bio-
technology Information (Bethesda, 
MD, USA) BLAST program (http://
blast.ncbi.nlm.nih.gov/Blast.cgi).
The mtLSU-rRNA fragment was 
ampliﬁ  ed from 11 lung and 8 placenta 
samples. Simultaneous DNA ampliﬁ  -
cation of 2 loci of P. jirovecii was ob-
served in lung tissue samples from 7 
(35%) of 20 fetuses and from 1 (5%) 
of 20 placenta samples. Sequencing 
of the mtLSU-rRNA gene showed 3 
polymorphisms, and DHPS gene anal-
ysis showed only wild-type genotype 
in all samples (Table).
Our results provide molecular 
evidence of P. jirovecii transplacental 
transmission in humans. No available 
data on the development of Pneumo-
cystis organisms in female genital 
organs was provided (8). In contrast, 
morphologic and molecular evidence 
of hematogenous dissemination of 
P.  jirovecii  from infected lungs has 
been provided by many authors (8). 
Pneumocystis  DNA has been docu-
mented in blood or amniotic ﬂ  uid 
samples from pregnant rabbit does 
(3), in which transplacental transmis-
sion of Pneumocystis spp. occurred. In 
humans, P. jirovecii colonization was 
observed in 5 (15.5%) of 33 pregnant 
women in their third trimester (9). 
These data suggest that physiologic 
immunodepression associated with 
pregnancy may favor Pneumocystis 
spp. colonization and mother-to-fetus 
transmission of the fungus by the he-
matogenous route. The transplacental 
route could enhance transmission of 
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Table. Pneumocystis jirovecii genotypes in samples identified as positive by nested 
PCR for 2 loci from fetal lung tissues and placenta samples* 
Lung tissues  Placenta tissues 
Case
mtLSU-rRNA 
genotype  DHPS genotype 
mtLSU-rRNA 
genotype  DHPS genotype 
C1 3 1 – –
C2 1 1 1 –
C3 3 1 – –
C4 3 1 – –
C5 2 1 1 –
C6 1 1 3 –
C7 1 1 – –
C8 – – 1 1
C9 3 – – –
C10 – – 3 –
C11 3 – 1 and 3  –
C12 1 and 3  – 1 –
C13 – – 1 –
C14 3 – – –
C15-C20 – – – –
*Genotype 1, polymorphism 85C/248C in mitochondrial large subunit (mtLSU)–rRNA gene and 55 
Trh/57 Pro inihydropteroate synthase (DHPS) gene; genotype 2, polymorphism in 85A/248C; 
genotype 3, polymorphism in 85T/248C. LETTERS
P.  jirovecii independent of environ-
mental hazards.
Isolation of pathogens from an 
aborted fetus does not necessarily 
mean that they have caused the death 
of the fetus because many agents ap-
pear to pass through the fetal-placental 
unit and cause little damage. Howev-
er, fungal infection is a major world-
wide cause of abortion in cattle (10), 
and the surprising high prevalence of 
P. jirovecii infection found in dead fe-
tuses in our study emphasizes the need 
to study the possible role of this fungal 
organism in human abortion.
Our ﬁ  ndings could be of potential 
clinical importance and could open a 
new  ﬁ  eld of research, which should 
be explored. Further research should 
assess the scope of the problem and 
design rational preventive strategies, 
if necessary.
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Avian Inﬂ  uenza 
Virus (H5N1) in 
Human, Laos 
To the Editor: The ﬁ  rst avian in-
ﬂ  uenza (H5N1) outbreak in poultry in 
Laos occurred in 2003 and subsided 
in March 2004 after massive killing 
of poultry to contain the disease. Ex-
tensive surveillance from July 2005 
through January 2006 did not detect 
any inﬂ  uenza virus subtypes in chick-
en, ducks, quails, and pigs in live bird 
markets in the Vientiane, Champa-
sak, and Savannakhet Provinces (1). 
Avian inﬂ   uenza virus (H5N1) was 
reintroduced into Laos in February 
2006 but showed a lower incidence. 
Viruses isolated in this country in 
2004 belonged to genotype Z, clade 
1, and 2006 isolates belonged to clade 
2.3.4 (online Appendix Figure, panel 
A, available from www.cdc.gov/EID/
content/15/1/127-appF.htm) (1).
Avian inﬂ  uenza (H5N1) had not 
been reported in humans in Laos un-
til February 27, 2007 (2). Our patient 
was a 15-year-old adolescent girl who 
lived in a suburb of Vientiane where 
an outbreak of inﬂ   uenza (H5N1) in 
poultry had been conﬁ  rmed on Febru-
ary 7, 2007. Inﬂ  uenza-like symptoms 
developed in the patient on February 
10. She was hospitalized in Vientiane 
with fever and respiratory symptoms 
on February 15. On February 17, her 
parents brought her to a private hospi-
tal in Nong Khai Province, Thailand. 
Oseltamivir was prescribed on Febru-
ary 19. On February 20, she was trans-
ferred to the Nong Khai Provincial 
Hospital because of rapid, progressive, 
severe pneumonia with acute respira-
tory distress syndrome. When we sus-
pected avian inﬂ  uenza in this patient, 
clinical specimens were tested.
A diagnosis of infection with 
avian inﬂ  uenza (H5N1) was based on 
positive results obtained by reverse 
transcription–PCR (RT-PCR), viral 
isolation in MDCK cells inoculated 
with an endotracheal suction specimen 
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